WallStreetZenWallStreetZen

NASDAQ: IRWD
Ironwood Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

IRWD past revenue growth

How has IRWD's revenue growth performed historically?
Company
7.83%
Industry
10.23%
Market
16.96%
IRWD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IRWD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IRWD's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IRWD earnings and revenue history

Current Revenue
$442.7M
Current Earnings
-$1.0B
Current Profit Margin
-226.4%

IRWD Return on Equity

Current Company
N/A
Current Industry
15.4%
Current Market
188%

Be the first to know when IRWD announces earnings.

IRWD Return on Assets

Current Company
-145.6%
Current Industry
3.4%
IRWD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IRWD Return on Capital Employed

Current Company
-460.13%
Current Industry
5.1%
IRWD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IRWD vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IRWD$442.74M-$895.55M-$1.00B+5.02%N/A
PCRX$674.98M$157.58M$41.96M+14.88%-90.17%
DCPH$163.36M-$187.94M-$194.94M+59.88%N/A
ANIP$486.82M$107.87M$17.15M+19.28%-8.07%
COLL$566.77M$308.33M$48.16M+15.11%+94.10%
View Top Pharmaceutical Stocks

IRWD earnings dates

Next earnings date
May 2, 2024

Ironwood Pharmaceuticals Earnings & Revenue FAQ

What were IRWD's earnings last quarter?

On Invalid Date, Ironwood Pharmaceuticals (NASDAQ: IRWD) reported Q4 2023 earnings per share (EPS) of $0.00, up 100% year over year. Total Ironwood Pharmaceuticals earnings for the quarter were -$1.09 million. In the same quarter last year, Ironwood Pharmaceuticals's earnings per share (EPS) was $0.31.

If you're new to stock investing, here's how to buy Ironwood Pharmaceuticals stock.

What was IRWD's earnings growth in the past year?

As of Q2 2024, Ironwood Pharmaceuticals's earnings has grown year over year. Ironwood Pharmaceuticals's earnings in the past year totalled -$1.00 billion.

What is IRWD's earnings date?

Ironwood Pharmaceuticals's earnings date is Invalid Date. Add IRWD to your watchlist to be reminded of IRWD's next earnings announcement.

What was IRWD's revenue last quarter?

On Invalid Date, Ironwood Pharmaceuticals (NASDAQ: IRWD) reported Q4 2023 revenue of $117.55 million up 9.66% year over year. In the same quarter last year, Ironwood Pharmaceuticals's revenue was $107.20 million.

What was IRWD's revenue growth in the past year?

As of Q2 2024, Ironwood Pharmaceuticals's revenue has grown 7.83% year over year. This is 2.4 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.23%. Ironwood Pharmaceuticals's revenue in the past year totalled $442.74 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.